CONTENT CALENDAR

DELIVER ON YOUR 2020 MARKETING OBJECTIVES

COMMERCIAL EXCELLENCE & MARKETING

HCPs and patients expect more. Personalisation, authenticity and purpose are our new mantras. To create real relationships with HCPs and patients you can’t continue on the same path. Data must become the lifeblood fuelling every engagement decision. Valuable, educational content must be your communication device. And delivery must be digitally-enabled, delivering exceptional experiences, rivalling those of the tech giants…now more than ever.

Case studies, discussions and thought-leadership content for following job titles

Managers, Director and VPs of:

  • Marketing
  • Sales
  • Commercial Excellence
  • Data & Analytics
  • Customer Experience
  • Customer Engagement

Case studies, discussions and thought-leadership content for following job titles

Managers, Director and VPs of:

  • Marketing
  • Sales
  • Commercial Excellence
  • Data & Analytics
  • Customer Experience
  • Customer Engagement

“eyeforpharma [now Reuters Events Pharma] has been an excellent partner for us in helping to build our pipeline and nurture relationships with decision-makers in the industry”

Marcus West, CEO, 60 Seconds

ceo image 60secons logo

JULY

  • Webinar – Asia & Australia sold out!
  • Virtual Workshops Europe 70% sold out!
  • Virtual Workshops North America 70% sold out!
  • Webinar Commercial & Marketing– Asia & Australia sold out!

SEPTEMBER

  • Virtual Workshops Europe 50% sold out!
  • Virtual Workshops North America
  • Webinar Commercial & Marketing x2 sold out!
  • Webinar Cell & Gene Therapy
  • Virtual Conference & Exhibition
    – Pharma Marketing USA 50% sold out!

OCTOBER

  • Webinar Digital Marketing sold out!
  • Webinar Commercial Strategy sold out!
  • Virtual Conference & Exhibition
    – Pharma Marketing Europe 50% sold out!

NOVEMBER

  • Webinar Patient Engagement
  • Webinar Japan
  • Webinar Australia
  • Webinar Commercial & Sales sold out!
  • Virtual Conference & Exhibition
    – Pharma Australia 30% sold out!
  • Pharma Awards Europe 40% sold out!

DECEMBER

  • Webinar Marketing & Commercial
  • Webinar Japan
  • Virtual Conference & Exhibition
    – Pharma & Patient Summit USA 40% sold out!
  • Pharma Awards USA 30% sold out!
case study icon

CONTENT CASE STUDY

Transform Customer Engagement through Intelligent Systems, Content and Data

This webinar showed attendees what a ‘modern, unified, intelligent backbone’ could provide for life sciences companies – where an integration between content, data models, business processes and analytics could mean we transcend the level of customer interaction and engagement that we have achieved so far. And finally hit the twin goals of better experience and more intelligent, personalised outreach.

target icon

TARGET JOB TITLES: Managers, Director and VPs of Marketing, Sales, Commercial Excellence, Data & Analytics, Customer Experience, Customer Engagement

TARGET COMPANIES:

Pfizer Novartis Lilly Abbvie Astrazeneca Janssen GSK Gilead Sanofi Merck Amgen Leo Bristol Myers Squibb Takeda Bayer Teva Eisai Ferring UCB Astellas Boehringer Ingelheim Celgene

KEY FACTS FROM THIS WEBINAR

key fact icon

1487

registrants
key fact icon

40%

opt-in leads for the sponsor
sales image
sales image

MEDICAL AFFAIRS

Medical Affairs has risen from zero to hero, fast becoming the most vital part of the pharma organisation. The pressure is now on, as medical teams must fuel stakeholder engagement, build real partnerships, perfect value demonstration and orchestrate cross-company evidence generation – all whilst ensuring that patient value is the guiding light. It’s time for Medical to understand its true role and ensure its position at the center of future success of the company.

Case studies, discussions and thought-leadership content for following job titles

Managers, Director and VPs of:

  • Medical Affairs
  • MSL Management & Development
  • Scientific Affairs
  • HEOR

Case studies, discussions and thought-leadership content for following job titles

Managers, Director and VPs of:

  • Medical Affairs
  • MSL Management & Development
  • Scientific Affairs
  • HEOR

“eyeforpharma [now Reuters Events Pharma] has been an excellent partner for us in helping to build our pipeline and nurture relationships with decision-makers in the industry”

Marcus West, CEO, 60 Seconds

ceo image 60secons logo

JULY

  • Webinar Medical Affairs – Asia & Australia – sold out!
  • Virtual Workshops – Europe 70% sold out!
  • Virtual Workshops – North America 70% sold out!

SEPTEMBER

  • Virtual Workshops Europe50% sold out!
  • Virtual Workshops North America
  • Webinar Real Word Evidence
  • Webinar Cell & Gene Therapy
  • Webinar Medical Affairs
  • Virtual Conference & Exhibition
    - Pharma & Patient Summit Europe 50% sold out!

OCTOBER

  • Webinar Real World Evidence
  • Webinar Medial Affairs
  • Webinar Market Access

NOVEMBER

  • Webinar Medical Affairs sold out!
  • Webinar Real World Evidence
  • Webinar Market Access
  • Webinar Japan
  • Virtual Conference & Exhibition
    – Pharma Australia 30% sold out!
  • Pharma Awards Europe 40% sold out!

DECEMBER

  • Webinar Medical Affairs
  • Webinar Market Access
  • Webinar Real World Evidence
  • Webinar Clinical
  • Webinar Patient Engagement
  • Webinar Japan
  • Virtual Conference & Exhibition
    – Pharma & Patient Summit USA 40% sold out!
  • Pharma Awards USA 30% sold out!
case study icon

CONTENT CASE STUDY

Whitepaper: The Digital Transformation of Medical, released Nov 2019

Within pharma companies, medical departments have steadily risen to prominence. As well as having a grip on key scientific, medical and compliance issues, medical staff must engage more deeply with customers while cultivating a new appreciation of the company’s commercial and strategic challenges. In all these endeavors, medical affairs must work with new types of data being generated from a multiplicity of sources inside and outside the organization.

“Pharma is several years behind the curve when innovating in digital areas other than medicine, and medical affairs is even further behind”

Christopher Keenan, Head of Medical Customer Engagement at BMS

target icon

TARGET JOB TITLES: Managers, Director and VPs of Medical Affairs, Digital and IT

TARGET COMPANIES:

Pfizer Novartis Lilly Abbvie Astrazeneca Janssen GSK Gilead Sanofi Merck Amgen Leo Bristol Myers Squibb Takeda Bayer Teva Eisai Ferring UCB Astellas Boehringer Ingelheim Celgene

KEY FACTS FROM THIS WEBINAR

key fact icon

1903

total number of Whitepaper downloads
key fact icon

58%


opt-in leads for the sponsor
sales image
sales image

“Pharma is several years behind the curve when innovating in digital areas other than medicine, and medical affairs is even further behind”

Christopher Keenan, Head of Medical Customer Engagement at BMS

PATIENT ENGAGEMENT

From clinical trials through to support programmes and strategic decision-making, we know that incorporating patients into design has untold benefits. But today’s efforts are mostly incremental adjustments of existing processes rather than wholesale change. Unfortunately, that means we are not delivering at the pace patients require.

Case studies, discussions and thought-leadership content for following job titles

Managers, Director and VPs of:

  • Medical Affairs
  • Patient Engagement
  • Patient Insights
  • Patient Experience

Case studies, discussions and thought-leadership content for following job titles

Managers, Director and VPs of:

  • Medical Affairs
  • Patient Engagement
  • Patient Insights
  • Patient Experience

“eyeforpharma [now Reuters Events Pharma] has been an excellent partner for us in helping to build our pipeline and nurture relationships with decision-makers in the industry”

Marcus West, CEO, 60 Seconds

ceo image 60secons logo

JULY

  • Webinar Patient Engagement sold out!
  • Webinar Commercial & Marketing x2 sold out!
  • Webinar Commercial & Marketing – Asia & Australia sold out!
  • Virtual Workshops Europe 70% sold out!
  • Virtual Workshops North America 70% sold out!

SEPTEMBER

  • Webinar Patient Engagement sold out!
  • Virtual Workshops North America
  • Webinar Cell & Gene Therapy
  • Webinar Commercial & Marketing x2 sold out!
  • Webinar Medical Affairs
  • Virtual Conference & Exhibition
    – Pharma & Patient Summit Europe 50% sold out!

OCTOBER

  • Webinar Patient Engagement sold out!
  • Webinar Commercial & Marketing sold out!
  • Webinar Clinical Trials/ Development
  • Virtual Conference & Exhibition
    – Marketing & Customer Innovation Europe 50% sold out!

NOVEMBER

  • Webinar Patient Engagement
  • Webinar Medical Affairs
  • Webinar Japan
  • Webinar Commercial & Marketing sold out!
  • Virtual Conference & Exhibition
    – Pharma Australia 30% sold out!
  • Pharma Awards Europe 40%sold out!

DECEMBER

  • Webinar Marketing & Commercial
  • Webinar Clinical Trials / Development
  • Webinar Japan
  • Virtual Conference & Exhibition
    – Pharma & Patient Summit USA 40% sold out!
  • Pharma Awards Europe 30%sold out!
case study icon

CONTENT CASE STUDY

Webinar: Harness behavioural science to solve the patient engagement puzzle

Behavioral science, combined with effective use of technology, provides a holistic, practical approach to patient engagement – addressing not just the clinical but also the psychosocial aspects of living with a condition. And when done well, it empowers patients to self-manage their own healthcare and build a new, positive journey. This webinar showed attendees how to:

  • See how behavioral science with patient-centric technology enables personalized support
  • Explore a ‘whole patient’ approach to meet patients where they are – mentally, not just physically

“Delivering webinars around helping pharma to integrate patient insights is always very rewarding given how much we can see it helps the industry deliver more value for patients”

Josh Bramwell, Head of Europe, Reuters Events Pharma

target icon

TARGET JOB TITLES: Managers, Director and VPs of Medical Affairs, Patient Engagement, Patient Insights, Patient Experience.

TARGET COMPANIES:

Pfizer Novartis Lilly Abbvie Astrazeneca Janssen GSK Gilead Sanofi Merck Amgen Leo Bristol Myers Squibb Takeda Bayer Teva Eisai Ferring UCB Astellas Boehringer Ingelheim Celgene

SPEAKERS : Alexion, Micromass, Novartis and Ashfield

KEY FACTS FROM THIS WEBINAR

key fact icon

2500

registrants
key fact icon

1250

live views
sales image
sales image

“Delivering webinars around helping pharma to integrate patient insights is always very rewarding given how much we can see it helps the industry deliver more value for patients”

Josh Bramwell, Head of Europe, Reuters Events Pharma

REAL WORLD EVIDENCE

Now, more than ever, is the time for real-world evidence (RWE) to come out of the shadows. You may have been saying this for years. But as we enter a new normal – a healthcare environment awakened to the remote, digital and data – RWE is increasing in importance. You will also know, achieving our real-world ambitions comes with a great many challenges. And whether they’re infrastructure, capability, cultural or technology related - those challenges, no matter how great the current need, still exist and must be overcome before regulatory and access decision-makers can fully embrace our ambitions. That’s where you step in...

Case studies, discussions and thought-leadership content for following job titles

Managers, Director and VPs of:

  • Epidemiology
  • RWE
  • HEOR
  • Scientific
  • Market Access
  • Medical Affairs

Case studies, discussions and thought-leadership content for following job titles

Managers, Director and VPs of:

  • Epidemiology
  • RWE
  • HEOR
  • Scientific
  • Market Access
  • Medical Affairs

“eyeforpharma [now Reuters Events Pharma] has been an excellent partner for us in helping to build our pipeline and nurture relationships with decision-makers in the industry”

Marcus West, CEO, 60 Seconds

ceo image 60secons logo

JULY

  • Webinar Medical Affairs – Asia & Australia sold out!
  • Virtual Workshops Europe 70% sold out!
  • Virtual Workshops North America 70% sold out!

SEPTEMBER

  • Virtual Workshops Europe 50% sold out!
  • Virtual Workshops North America
  • Webinar Real World Evidence
  • Webinar Market Access
  • Webinar Cell & Gene Therapy

OCTOBER

  • Webinar Real World Evidence
  • Webinar Medical Affairs
  • Webinar Market Access

NOVEMBER

  • Webinar Real World Evidence
  • Webinar Medical Affairs sold out!
  • Webinar Market Access
  • Webinar Japan
  • Virtual Conference & Exhibition
    – Pharma Australia 40% sold out!

DECEMBER

  • Webinar Japan
  • Webinar Medical Affairs
  • Webinar Market Access
  • Webinar Real World Evidence
  • Webinar Clinical
case study icon

CONTENT CASE STUDY

Webinar: The RWE Regulatory Evolution: How to use RWE to augment RCTs and advance the drug development paradigm

Real-world evidence (RWE) has had increased impact on the development and commercialization of new treatments. Now, the FDA, prompted by the 21st Century Cures Act, is engaged in a multi-year process to determine exactly how RWE can augment or even substitute randomized clinical trials (RCTs), to get the right treatment to the right patient faster and safely. As part of this commitment, Brigham and Women’s Hospital, Harvard Medical School, and Aetion have collaborated to launch RCT DUPLICATE, an FDA-funded demonstration project in which real-world data is used to replicate the findings of 30 completed Phase III and IV randomized control trials, and to predict the results of seven ongoing Phase IV trials. The project aims to identify when, where, and how RWE sourced from healthcare databases can answer key questions in drug development. This webinar (a) shares interim findings and (b) determines how pharma can apply the study’s interim findings to launch a new era in which pharma can have confidence in scientifically valid real-world evidence.

“Bringing cutting-edge research to this webinar helped it attract a lot of interest from a very targeted pharma audience.”

James Mackintosh, Head of Product, Reuters Events Pharma

target icon

TARGET JOB TITLES: Managers, Director and VPs of Epidemiology, RWE, HEOR, Scientific, Market Access, Medical Affairs.

TARGET COMPANIES:

Pfizer Novartis Lilly Abbvie Astrazeneca Janssen GSK Gilead Sanofi Merck Amgen Leo Bristol Myers Squibb Takeda Bayer Teva Eisai Ferring UCB Astellas Boehringer Ingelheim Celgene

KEY FACTS FROM THIS WEBINAR

key fact icon

1521

registrants
key fact icon

1221

total views(live and on demand)
sales image
sales image

“Bringing cutting-edge research to this webinar helped it attract a lot of interest from a very targeted pharma audience.”

James Mackintosh, Head of Product, Reuters Events Pharma

MARKET ACCESS

Regulators, payers and HTAs are changing. Clear themes are emerging, including harmonisation, increasingly bespoke agreements and the consideration of new forms of evidence. But these are not solutions - health systems remain close to breaking point, with industry and payers often failing to reach agreement on value and affordability. We must now harness maturing RWE and digital capabilities to advance access approaches and create a more affordable, value-driven system. Pharma leaderships from across functional areas need to come together with key market access authorities and pharma market access experts to accelerate harmonisation and spark our next evolutionary leap forward.

Case studies, discussions and thought-leadership content for following job titles

Managers, Director and VPs of:

  • Epidemiology
  • RWE
  • HEOR
  • Scientific
  • Market Access
  • Medical Affairs

Case studies, discussions and thought-leadership content for following job titles

Managers, Director and VPs of:

  • Epidemiology
  • RWE
  • HEOR
  • Scientific
  • Market Access
  • Medical Affairs

“eyeforpharma [now Reuters Events Pharma] has been an excellent partner for us in helping to build our pipeline and nurture relationships with decision-makers in the industry”

Marcus West, CEO, 60 Seconds

ceo image 60secons logo

JULY

  • Webinar Medical Affairs – Asia & Australia sold out!
  • Virtual Workshops Europe 70% sold out!
  • Virtual Workshops North America 70% sold out!

SEPTEMBER

  • Virtual Workshops Europe 50% sold out!
  • Virtual Workshops North America
  • Webinar Real World Evidence
  • Webinar Market Access
  • Webinar Cell & Gene Therapy

OCTOBER

  • Webinar Real World Evidence
  • Webinar Medical Affairs
  • Webinar Market Access

NOVEMBER

  • Webinar Real World Evidence
  • Webinar Medical Affairs sold out!
  • Webinar Market Access
  • Webinar Japan
  • Virtual Conference & Exhibition
    – Pharma Australia 40% sold out!

DECEMBER

  • Webinar Japan
  • Webinar Medical Affairs
  • Webinar Market Access
  • Webinar Real World Evidence
  • Webinar Clinical
case study icon

CONTENT CASE STUDY

Webinar: The RWE Regulatory Evolution: How to use RWE to augment RCTs and advance the drug development paradigm

Real-world evidence (RWE) has had increased impact on the development and commercialization of new treatments. Now, the FDA, prompted by the 21st Century Cures Act, is engaged in a multi-year process to determine exactly how RWE can augment or even substitute randomized clinical trials (RCTs), to get the right treatment to the right patient faster and safely. As part of this commitment, Brigham and Women’s Hospital, Harvard Medical School, and Aetion have collaborated to launch RCT DUPLICATE, an FDA-funded demonstration project in which real-world data is used to replicate the findings of 30 completed Phase III and IV randomized control trials, and to predict the results of seven ongoing Phase IV trials. The project aims to identify when, where, and how RWE sourced from healthcare databases can answer key questions in drug development. This webinar (a) shares interim findings and (b) determines how pharma can apply the study’s interim findings to launch a new era in which pharma can have confidence in scientifically valid real-world evidence.

“Bringing cutting-edge research to this webinar helped it attract a lot of interest from a very targeted pharma audience.”

James Mackintosh, Head of Product, Reuters Events Pharma

target icon

TARGET JOB TITLES: Managers, Director and VPs of Epidemiology, RWE, HEOR, Scientific, Market Access, Medical Affairs.

TARGET COMPANIES:

Pfizer Novartis Lilly Abbvie Astrazeneca Janssen GSK Gilead Sanofi Merck Amgen Leo Bristol Myers Squibb Takeda Bayer Teva Eisai Ferring UCB Astellas Boehringer Ingelheim Celgene

KEY FACTS FROM THIS WEBINAR

key fact icon

1521

registrants
key fact icon

1221


total views(live and on demand)
sales image
sales image

“Bringing cutting-edge research to this webinar helped it attract a lot of interest from a very targeted pharma audience.”

James Mackintosh, Head of Product, Reuters Events Pharma

CLINICAL

If you ask pharma’s c-suite where to look for real innovation is, for the first time in a very long time, their answer is “clinical”. These seeds of change, driven by patient centric and digital transformations, have been given rocket fuel. The COVID-19 pandemic has created an environment where fear of failure is no longer an option. Pharma must digitally transform its recruitment and retention, data and evidence generation strategies. While regulators must embrace new types of trial, be it synthetic, patient-preferred, siteless or virtual. Resistance to innovation is futile.

Case studies, discussions and thought-leadership content for following job titles

Managers, Director and VPs of:

  • Clinical development
  • Clinical operations
  • Clinical innovation
  • Medical affairs
  • Scientific Affairs

Case studies, discussions and thought-leadership content for following job titles

Managers, Director and VPs of:

  • Clinical development
  • Clinical operations
  • Clinical innovation
  • Medical affairs
  • Scientific Affairs

“eyeforpharma [now Reuters Events Pharma] has been an excellent partner for us in helping to build our pipeline and nurture relationships with decision-makers in the industry”

Marcus West, CEO, 60 Seconds

ceo image 60secons logo

JULY

  • Webinar Clinical sold out!
  • Webinar Medical Affairs – Asia & Australia sold out!
  • Virtual Workshops Europe 70% sold out!
  • Virtual Workshops North America 70% sold out!

SEPTEMBER

  • Webinar Clinical
  • Webinar Real World Evidence
  • Webinar Market Access
  • Virtual Workshops Europe 50% sold out!
  • Webinar Cell & Gene Therapy
  • Virtual Conference & Exhibition
    – Pharma & Patient Summit Europe 50% sold out!

OCTOBER

  • Webinar Clinical
  • Webinar Real World Evidence
  • Webinar Medical Affairs

NOVEMBER

  • Webinar Clinical
  • Webinar Real World Evidence
  • Webinar Medical Affairs
  • Webinar Patient Engagement
  • Virtual Conference & Exhibition
    – Pharma Australia 40% sold out!

DECEMBER

  • Webinar Clinical
  • Webinar Medical Affairs
  • Webinar Real World Evidence

CONTENT CASE STUDY

Webinar: Harness behavioural science to solve the patient engagement puzzle

Behavioral science, combined with effective use of technology, provides a holistic, practical approach to patient engagement – addressing not just the clinical but also the psychosocial aspects of living with a condition. And when done well, it empowers patients to self-manage their own healthcare and build a new, positive journey. This webinar showed attendees how to:

  • See how behavioral science with patient-centric technology enables personalized support
  • Explore a ‘whole patient’ approach to meet patients where they are – mentally, not just physically

“It was clear this topic was an important one for pharma with a very good number of registrants for a relatively niche topic. Digital endpoints are a topic we will be delivering more content on, in the future”

Blair Gottscho, Managing Director, Reuters Events Pharma

TARGET JOB TITLES: Managers, Director and VPs of Medical Affairs, Patient Engagement, Patient Insights, Patient Experience.

TARGET COMPANIES:

Pfizer Novartis Lilly Abbvie Astrazeneca Janssen GSK Gilead Sanofi Merck Amgen Leo Bristol Myers Squibb Takeda Bayer Teva Eisai Ferring UCB Astellas Boehringer Ingelheim Celgene

SPEAKERS : Alexion, Micromass, Novartis and Ashfield

KEY FACTS FROM THIS WEBINAR

key fact icon

2500

registrants
key fact icon

1250

live views
sales image
sales image

“It was clear this topic was an important one for pharma with a very good number of registrants for a relatively niche topic. Digital endpoints are a topic we will be delivering more content on, in the future”

Blair Gottscho, Managing Director, Reuters Events Pharma

CONTACT THE TEAM

We’re here to help support your marketing objectives and we are keen to align you with the right content!

Blair Gottscho

VP Operations

Izzy Gladstone

VP Marketing

Karla Sharp

Head of North America

Hannah Brady

International Project

Henry Payne

Director of Business Development

Saskia Burbach

International Project Director

Liz Swift

Head of Partnerships

Ed Harris

Director of Business Development

Joseph Hargreaves

Director of Business Development

Alex Norman

Director of Business Development - Clinical